The Canadian Clinical Trials Asset Map (CCTAM) will be launched on June 4, 2015 at a breakfast event, jointly hosted by the Canadian Clinical Trials Coordinating Centre (CCTCC) and Research Canada; with guest speaker – The Hon. Senator Kelvin Ogilvie.
The CCTAM will help Canada market itself as the ideal destination for clinical research. It is a unique, robust, searchable web-based database providing a comprehensive picture of the breadth and depth of Canada’s clinical research assets.
Clinical trials help provide access to new, potentially life-saving medications, vaccines and therapies and support local economies.
The CCTAM is overseen by the CCTCC which was created to implement the Action Plan to strengthen and improve clinical trials in Canada and streamline processes for companies and researchers.
The Action Plan to help attract more clinical trials to Canada was spearheaded by Canada’s Research-based pharmaceutical companies (Rx&D), the Canadian Institutes of Health Research (CIHR), and HealthCareCAN.
For more information, visit: CCTAM.